Vancouver, British Columbia and
Toronto, Ontario -- December 12, 2017 -- InvevstorsHub
NewsWire -- Blox Labs Inc. (“BLOX” or the “Company”) (CSE: BLOX)
(FSE: BR1B) is pleased to announce that, in partnership with
Liberty Leaf Holdings Ltd. (“LIB”) (
CSE:
LIB) (
OTC:
LIBFF) (FSE: HN3P), it has commenced development of
“
cannaBLOX”, a Blockchain-based smart contract
supply chain management platform for the legalized Cannabis
industry.
The cannaBLOX Blockchain software will aim to ease and obliterate
logistical bottlenecks, ensure product safety and quality of
supply, minimize fraud and potential criminal activity, and assist
with taxation and regulatory compliance across various levels of
government within the legalized Cannabis marketplace. Phase 1
development of cannaBLOX has begun and will include, among other
things, refining project scope and modelling itemization, an
environmental scan of the Canadian Cannabis landscape, cannaBLOX
branding, and the completion of a Blockchain Whitepaper.
Instrumental to the development of cannaBLOX and the integration of
a workable logistics framework will be Jeff Zanini, Director and
Senior Advisor to BLOX, who has over 25 years of experience as an
accomplished Senior Executive in Canada’s logistics sector, along
with his BLOX team of industry and technical experts.
Liberty Leaf’s wholly-owned subsidiary, North Road Ventures, is a
late-stage Access to Cannabis for Medical Purposes Regulations
(ACMPR) applicant, focused on the value-added side of the medicinal
and legalized cannabis market - product processing, sales and
supply chain management. Specifically, North Road aims to be the
interface between artisan Cannabis cultivators and licensed
retailers, ensuring an efficient and seamless supply of quality
dried cannabis, cannabis oils and other related products containing
THC and CBD. Will Rascan, President and CEO of LIB, commented, “A
vital component of not only our sales and distribution focused
model at North Road, but of a nationwide recreational and medical
Cannabis landscape, will be the transparent traceability and
documentation of Cannabis products across the supply chain.” He
continued, “As with any pharmaceutical or food grade product,
consumers deserve to know that the product they are consuming is of
the utmost in quality. We are very excited to be amongst the first
movers in applying Blockchain technology to the Cannabis sector as
I believe that seed-to-sale provenance verification will quickly
become the industry norm.”
In a recent request for public feedback from the Government of
British Columbia, IBM submitted a proposal suggesting the use of
Blockchain technology as a means by which to track and document
transactions across the Cannabis supply chain. In a November
article from Bloomberg, IBM stated: “This type of transparency
would bring a new level of visibility and control to the provincial
regulators.”
“The use of Blockchain and decentralized application technologies
is a natural fit to address the potential pain points that are
presented in a complex marketplace such as recreational and medical
cannabis,” noted Harald Seemann, CEO and Director of BLOX. “Our
objective as a technology company is to develop commercial software
solutions utilizing emerging trends in Blockchain, Smart Contracts
and Decentralized Application Technologies. This partnership with
Liberty Leaf on the development of cannaBLOX provides us with an
exciting opportunity to be at the forefront of two burgeoning and
intersecting sectors, Cannabis and Blockchain.”
About BLOX Labs
Blox Labs Inc. (CSE: BLOX) (FSE: BR1B) is a boutique technology
development company that is focused on creating best-in-class
software solutions that are driven by emerging trends in
Blockchain, Smart Contracts and Decentralized Application
Technologies. BLOX is actively targeting strategic acquisitions of
high growth companies in the technology sector and is open to
partnerships.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a Canadian-based public company whose
focus is to build and support a diversified portfolio of
cannabis-sector businesses, including cultivation, processing,
value-added CBD/THC pet products, and supply chain management.
Liberty Leaf also owns 100% of North Road Ventures, a late-stage
applicant under Health Canada’s Access to Cannabis for Medical
Purposes Regulations (ACMPR), a company focused on product
processing, sales and complementary distribution - the value-added
spectrum of the business. Furthermore, Liberty Leaf recently
announced a 60% interest stake in Just Kush, a late-stage ACMPR
applicant and owns complete control over a current Medical
Marijuana Access Regulations (MMAR)-licensed production
facility.